Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-174419

Options or other derivatives

  • Chief Operating Officer acquired 8,669 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jacobson Mark L. · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-21 Grant or award : show line 1 in the form Performance Stock Units +8,669 8,669 D
Loading xslF345X06/ownership.xml…